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Summary
Transgenic mice carrying and expressing the human CD3e gene incorporate the corresponding
protein product into T cell receptor (TCR)/CD3 complexes on thymocyte and T cell surfaces.
The chimeric antigen receptors allow normal T cell development and selection of repertoires
in vivo and are able to transduce activation signals in vitro. We have exploited the ability to
distinguish mouse (m) and human (h)CD3e chains to analyze the stoichiometry of CD3e in
transgenic mouse TCRs. Immunoprecipitation and fluorescence resonance energy transfer ex-
periments demonstrate that such TCRs can contain both h- and mCD3e chains, implying that
more than one CD3e subunit occurs per TCR. Antigen comodulation studies are consistent
with a stochastic use ofh- or mCD3e during receptor assembly, and further suggest a structure
for the TCR/CD3 complex with two CD3e chains. The determination ofCD3e subunit stoichiom-
etry, together with existing biochemical data, allows the generation of a minimal model for
the structure of the TCR and illustrates the potential value of the transgenic approach to the
analysis of complex receptors.
T
CRs for antigen (TCR/CD3) comprise two types of
component: (a) two variable subunits (TCRa/for -y/S)
that specifically bind antigen; and (b) several invariable chains
that are noncovalently associated with TCR chains (1, 2).
The invariant chains are implicated in the assembly and regu-
lation of surface expression of the TCR/CD3 complex (3-8),
as well as in the transduction of antigen-driven activation
signals (3, 8-11), and consist of the products of the CD3
gene family itself (CD3y, CD3S, CD3e), and the ~ and 17
chains, which are structurally unrelated to CD3 (12-17).
In spite of the rapid progress in our knowledge about the
individual subunits, we have limited information about the
quaternarystructure of the compound receptor. The general
view has been that the subunit stoichiometry of TCR/CD3
complex is either oiOybe~2 or ctfyberq (18-20). However,
we are not aware of any previous studythat accurately quan-
titates the number of individual chains, and therefore, data
supporting the above representation of TCR/CD3 subunits
are lacking.
It is difficult to establish the stoichiometry of compound
receptors in which associations are via noncovalent bonds,
as occurs for many of the subunits of the TCR/CD3 com-
plex. We reasoned that one method of calculating the mul-
tiplicity of individual subunits might be to study receptors
that bear polymorphic forms of a given subunit, which can
thus be experimentally distinguished. Transgenic mice facili-
tate such an approach when the introduced gene is poly-
morphic with respect to its endogenous counterpart. Here,
we have exploited interspecies polymorphism and analyzed
CD3e subunit stoichiometry using T cells from human CD3e
transgenic mouse strains (21). We report that both mouse
and human CD3e chains can be present in the same TCR/CD3
complex, on T cells that have undergone normal TCR selec-
tion in vivo and bear surface receptors that transduce activa-
tion signals in vitro, indicating that the TCR contains two
CD3e subunits.
Material and Methods
Transgenic Mice.
￿
A preliminary description of transgenic mice
strains carrying and expressing the human CD3e gene has been
published (21), andfurther details will be givenelsewhere(Olsson,
C.;et al., manuscript in preparation).Briefly, five independent strains
were constructed by injection ofBDF2 fertilized eggs with Not1-
linearized cosmid (cc-1; 13) DNA. The initial backcross offounder
mice was with the C57BL/6 inbred strain, and positive hemizy-
gous offspring were subjected to brother/sister mating. Resultant
homozygotes were maintained as established transgenic lines from
founder mice with low transgene copy numbers (TG16, one copy;
TG21, threecopies; TG41, five copies). High-copy strains (TG22:
-40 copies; TG31: -90 copies) produced homozygotes infre-
quently, and in most cases, these mice did not thrive. During the
establishment of theTG strains, we observed that 7of 10 of hemizy-
gous mice carrying high-copy (i.e., -40or 90) and 1 of 16 having
low-copy (i.e., one, three, or five) numbers of the transgene had
a small spleen and a thymus that was barely detectable. Accord-
ingly, thymocyte numbers were severely reduced to -2 x
106/thymus (range, 1-8 x 106/thymus), whilecontrols contained
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normal T cell numbers. Both thymocytes and spleen T cells in such
immunodeficient mice showed significantly reduced levels ofboth
mouse (m)'- m and human (h) CDR on the cell surface (our un-
published observations). Although the immunodeficiency was not
strictly related to copy number or transgene integration site, its
prevalence in the high-copy mice may be at least partially respon-
sible for our difficulties in establishing viable homozygotes from
these lines. The immunodeficient phenotype was not observed in
the homozygous transgenic mice, described in this report.
Antibodies.
￿
We used mAb specific for either human antigens
CD3e (UCHT1; 22) and CD2 (Leu-5b; Becton Dickinson & Co.,
Mountain View, CA [B-DI); mouse antigens CD3E (145-2C11; 23),
L3T4 (mCD4; B-D), Lyt-2 (mCD8; B-D), Thy-1 (B-D), I-Ed
(14.4.4; American Type Culture Collection, Rockville, MD),
par1TCR/3 (H57-597; 24), TCRV,3 (536; 25), TCRVp11 (RR3-15;
26), TCRVs6 (RR4-7; 27), and TCRVse (F23.1; 28); and antisera
specific for either human, mouse, or hamster Ig (Southern Biotech-
nology Associates, Birmingham, AL). Where indicated, antibodies
were conjugated with either FITC, tetramethylrhodamine iso-
thiocyanate (TRITC), or biotin, as described elsewhere (29).
CellLines, Proliferation, and Cytotoxicity Assays.
￿
JM and B6.2.16
BW2.1 are human and mouse T cell lines, respectively; U937 is
an Ig FcR-bearing human histiocytoma. T cell lines from either
transgenicand control littermate mouse or human origin were pre-
pared as previously described (21) . The proliferation and "Cr re-
lease cytotoxicity assays were performed according to standard
methods detailed elsewhere (21, 30).
Cell Surface Labeling and Itnmunoprecipitation.
￿
Approximately
2 x 10' cells of each line were labeled with Na'"I by lactoper-
oxidase-catalyzed cell surface iodination. Labeled membrane pro-
teins were then extracted under conditions that disrupt (20 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 2 MM MgCIZ, 2% NP-40,
1 mM PMSF) or preserve (50 mM Tris-HCI, pH 8.0,150 mM NaCl,
2 MM MgCIZ, 1% digitonin, 1 mM PMSF) the noncovalent as-
sociations of the TCR/CD3 complex. Lysates were precleared for
30 min at room temperature (RT) with 2 pl ofa mixture of mouse
and hamster serum, plus 50 )AI of PBS-washedprotein GSepharose
(Pharmacia Fine Chemicals, Uppsala, Sweden). Recovered super-
natants were then aliquoted and mAb UCHT1 (100 pl tissue cul-
ture supernatant) or 145-2C11 (5 p,l purified antibody), or rodent
serum (1 P1) was added followed by 50 p,l protein G-Sepharose
(1 h, RT, with gentle rotation) . Sepharose beads were then washed
three times at RT in their respective lysis buffers, before boiling
in reducing sample buffer and analysis by 10% PAGE.
Immunofuorescence and Fluorescence Resonance Energy Transfer .
The distribution of surface antigens was determined by direct or
indirect immunofluorescence, as described elsewhere (30), using
a FACScan analyzer (B-D). List-mode information from 10' viable
cells was accumulated for each analysis. Surface modulation of the
TCR/CD3 complex was performed as described by Meuer et al.
(31). We used a FRCS to determine energy transfer between T cell
surface molecules bound by FITC- and TRITC-labeled mAb, as
described in detailby Szollosi et al. (32). Briefly, FITC and TRITC
were sequentially excited at 488 and 514 rim, respectively. By using
suitable filter combinations, we detected FITC and TRITC emis-
sions at 535 min (filter bandpath width of 15 nm) and >590 nm,
respectively. Compensation parameters were determined from data
obtained using single-labeled cells. Results represent the efficiency
'Abbreviations used in this paper: FRET, fluorescence resonance energy
transfer; h, human; m, mouse; RT, room temperature; TRITC, tetramethyl-
rhodamine isothiocyanate.
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of fluorescence resonance energy transfer (FRET 32-34), where
the efficiency of transfer of (nonradiative) energy from donor to
acceptor is determined by measuring fluorochrome acceptor emis-
sion as well as the quenching of donor fluorescence emission (radi-
ated photons). The efficiency of transfer is directly related to the
average donor-acceptor distance (33), antigens in higher abundancy
being preferred as acceptors (32-34).
Results
Analysis of CD3E Subunit Stoichiometry Using Transgenic
Mice. We decided to quantitate the number ofCD3E subunits
in the TCR/CD3 complex by taking advantage of the unique
coexpression of two distinguishable CD3E chains on the T
cell surface in hCD3E transgenic mice (21). Five independent
strains of transgenic mice were constructed using a cosmid
containing the hCD3E gene and the cis-acting elements re-
quired for its appropriate expression. The five strains con-
tained from 1 to 90 copies of the hCD3E gene and were all
found to express hCD3E mRNA in the correct T cell-specific
fashion as defined by Northern blot assays (Ollson, et al .,
manuscript in preparation). T cells derived from indepen-
dent transgenic strains were submitted to analyses of the
subunit associations between the introduced hCD3e and the
endogenous TCR/CD3 components. In particular, we asked
whether h- and mCD3E subunits occur in the same TCR/CD3
complex by using species-specific anti-CD3E mAb in im-
munoprecipitation, energy transfer, and surface modulation
studies.
Coprecipitation of h- and mCD3E from Transgenic Mouse T
Cells. Initially, we carried out immunoprecipitation studies
using surface-labeled cells and mAb specific for either hCD3E
or mCD3E . 1251-labeled cells were first lysed using detergent
conditions that dissociate TCR heterodimer and CD3 sub-
units. Under these conditions (Fig. 1 A), anti-hCD3E mAb
UCHT1 specifically immunoprecipitated a 20-kD polypep-
tide from T cell lines derived from transgenic mice strains
TG16 and TG41 that comigrates with CD3E from the human
T cell lineJM. A distinct 25-kD species that comigrates with
mCD3e from nontransgenic littermate T cells was immuno-
precipitated by anti-mCD3E mAb 145-2C11 from a popula-
tion of transgenic mouse T cells. Thus, the difference in the
molecular weights of h- and mCD3 chains allowed us readily
to detect their surface coexpression in the transgenic mouse
T cells.
We then analyzed the interaction between the two CD3E
subunits and the other endogenous TCR/CD3 components
by using aliquots of 125I-labeled cells that were lysed under
detergent conditions that preserve TCR/CD3 association.
As shown in Fig. 1 B, the endogenous 25-kD mCD3E subunit,
as well as the 41-45-kD TCR dimer, were coimmunoprecipi-
tated together with the 20-kD hCD3E by either anti-mCD3E
or anti-hCD3E mAb from the surface of transgenic mouse
T cells. The specificity ofthe coprecipitation ofh- and mCD3E
was confirmed using human and mouse T cell lines as con-
trols in parallel experiments. A transgene-negative littermate
gave very similar results to those of the mouse T cell line
(not shown).The coprecipitation of h- and mCD3e in the digitonin ly-
sates (Fig . 1 B) shows that a proportion ofTCR/CD3 com-
plexes contains at leasttwo CD3e subunits. The lack ofsuch
coprecipitation in the NP40 lysates (Fig. 1 A) implies that
the predominant association of h- and mCD3e is not due
to strong, direct e-e interactions .
Fluorescence Resonance Energy Transfer between h- andmCD3e
Subunits. We examined further the physical relationship be-
tween the human and endogenous CD3e chains by using a
different experimental method : flow cytometric analysis and
FRET. FRET has been used successfully to determine intra-
and intermolecular distances at the 2- to 10-nm level in single
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Figure 1 .
￿
Coprecipitation o£h- and mCD3e in T cells
from transgenic mice. The indicated human, mouse, or
hCD3e transgenic mice T cell lines were surface iodinated
and aliquots lysed under conditions that either disrupt
(A) or preserve (B) the noncovalent associations of the
TCR/CD3 complex . Lysates were submitted to precipi-
tation with antibodies specific for either hCD3e (UCHTI)
or mCD3e (145-2C11), or with control rodent sera, fol-
lowed by 10% PAGE . The autoradiogram was exposed
for 48 h . Bold arrows indicate the localization ofh- and
mCD3e in thegel. The precipitation pattern of the mouse
T cell using mAb 145-2C11, specific for mCD3e, shows
that, under the conditions used, mCD3y (which has a
similar size to hCD3e) is very poorly labeled and is not
detected . In the corresponding immunoprecipitation with
themAb specific for human MR, some of the 25-26-
kD region may contain mouseCD36 in addition tomouse
CD3e .
cells (32-34) . In our study, we used mAbs against mCD3e
and hCD3e that were suitably labeled with either FITC or
TRITC . FITC is excited at x+488 nm and can serve as non-
radiative energy donor for a nearby (<10-nm distant) TRITC
acceptor molecule. The relative spatial distribution of the
binding sites for FITC-anti-mCD3e and TRITC-anti-hCD3e
was investigated in mouse transgenic T cells. Cells labeled
with both conjugated mAb were analyzed to measure the
efficiency of energy transfer. The fluorescence distribution
found implies energy transfer (Table 1) and indicates that anti-
mCD3e and anti-hCD3e mAbs and their respective binding
sites are in close proximity (<10nm) . The reciprocal donor-Table 1.
￿
Fluorescence Resonance Energy Transfer between Donor-Acceptor Pairs of mAb
T cells
￿
Donor (FITC)
￿
Acceptor (TRITC)
￿
T'
￿
TG16
￿
TG41
￿
Transfer
CDR transgenic mice:
mCD3e
￿
hCD3e
￿
4°C
￿
11 .3, 10.7
￿
12.3, 10.2
￿
Yes
hCD3e
￿
mCD3e
￿
4°C
￿
12.9, 11.2
￿
10.6, 11 .0
￿
Yes
hCD3e
￿
mTCRO
￿
4°C
￿
13 .7, 13.4
￿
ND
￿
Yes
mCD3e
￿
mTCRO
￿
4°C
￿
13 .8, 14.0
￿
ND
￿
Yes
mCD3e
￿
CD4 + CD8
￿
4°C
￿
0.4, 0.6
￿
0.7, 0.3
￿
No
hCD3e
￿
CD4 + CD8
￿
4°C
￿
0.3, 0.5
￿
0.9, 0.2
￿
No
mCD3e
￿
CD4 + CD8
￿
37°C
￿
8 .4, 7.3
￿
9.6, 7.5
￿
Yes
Nontransgenic littermate:
mCD3e
￿
hCD3e
￿
4°C
￿
0.3, 0.1
￿
0.4, 0.2
￿
No
Spleen T cells from either CD3e transgenic or control littermate mice were enriched using nylon wool columns (21). The frequency distribution
of energy transfer efficiency between fluoresceinated (FITC) and rhodaminated (TRITC) mAbs specific for the indicated antigens on the surface of
transgenic T cells was measured by flow cytometry. The cells were incubated with the antibodies for 60 min at the indicated temperatures (T.) .
Mean efficiency of transfer is displayed for T cells from two individual mice for either the TG16 or the TG41 strains, and control littermates. The
interpretation of energy transfer results, where "Yes" corresponds to transfer efficiency of >,2%, is indicated in the Transfer column.
acceptor combination, FITC-anti-hCD3e and TRITC-anti-
mCD3e, yielded similar results. The m- and hCD3e-specific
pair of mAbs used did not induce energy transfer in non-
transgenic T cells.
When similar experiments were carried out using donor/ac-
ceptor antibody pairs specific for either h- or mCD3e and
mTCR-0, values of efficiency of FRET were in agreement
with the hCD3e/mCD3e pair results (Table 1). This indi-
cates that both the h- and mCD3e chains and the TCR-/3
are in close proximity to each other.
Neither TRITC-anti-CD4 nor TRITC-anti-CD8 mAb,
which bind to antigens that are about fourfold more abun-
dant on the T cell surface, acted as acceptors in combination
with a FITC-anti-CD3e mAb donor (Table 1). It is worthy
to note that energy transfer between anti-CD4 and anti-CD3
fluorochrome-tagged mAb can take place at 21-37°C after
microaggregation of surface molecules, but does not occur
at 4°C (34; Table 1). This rulesour artifactual energy transfer
occurring between distant molecules under our working
conditions (32-34). The FRET results show that the hCD3e-
mTCR/CD3 association first detected by immunoprecipitation
occurs in all transgenic T cells, and notjust in a subpopulation.
Partial comodulation Implies Random Association of h- and
mCD3e. The above results imply that the TCR/CD3 com-
plex contains at leasttwo CD3e subunits. IfhCD3e can struc-
turally substitute for mCD3e, the existence of TCR/CD3
complexes containing only either hCD3e or mCD3e subunit
pairs should be detectable. We examined this possibility by
modulation of the surface expression of either hCD3e or
mCD3e subunits and subsequent immunofluorescence and
flow cytometry analysis of the reciprocal chain with specific
mAb (Fig. 2). Although anti-mCD3e mAb removed most
10
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Efficiency (mean percent)
(-95%) of surface mCD3e, the expression of hCD3e was
only reduced by -60% as compared with modulation with
anti-hCD3e mAb. Similarly, anti-hCD3e mAb removed only
a portion (ti50%) of mTCR/CD3 complexes in every cell
after virtually complete modulation of hCD3e antigen. In
contrast, >95% of both hCD3e and mCD3e comodulated
with TCR-a/O (Fig. 2), indicating that both types ofCD3e
subunit are integral antigen receptor components. The
specificity of the comodulation was confirmed using Thy-1
antigen as control.
These data are consistent with a TCR/CD3 complex that
randomly assembles hCD3e and mCD3e subunits within a
single receptor, the simplest interpretation being that each
complex contains two CD3e chains. Given random usage of
either h- or mCD3e in the transgenic mice, a ratio of 1:2:1
of the three species of TCR (comprising m/m-, h/m-, and
h/hC133e, respectively) would result. Therefore, since me
is represented twice in the me/me TCR/CD3 species, half
of the surface mCD3e would be found in he/me-type
receptors, and half in me/me complexes, when expressed in
molar amounts. In this case, antibodies against hCD3e would
be expected to comodulate half of the mCD3e chains from
the cell surface, which is close to the experimental result.
For hypothetical receptor complexes with three (or more)
CD3e chains, HCD3e-specific antibodies should comodulate
75% (or more) ofthe surface mCD3e, which is not observed
experimentally. The antigen comodulation data, therefore,
strongly suggest a stoichiometry of two CD3e subunits per
TCR.
Analysis of T Cell Development in hCD3e Transgenic Mice.
We were concerned to demonstrate that the chimeric antigen
receptors behaved normally in the transgenic mice, and there-11
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Zfore, that their function, and hence structure, reflected that
found in normal mice. Along these lines, we compared by
immunofluorescence and flow cytometry the thymocyte and
peripheral lymphoid populations in transgenic and control
mice to study the putative effects of transgene expression upon
T cell development in vivo. First, we studied the effect of
the transgene upon the level of CD3 expression. As shown
in Fig. 3 A, subpopulations (49, 35, and 16%, respectively)
oftransgenic thymocytesbear either no, low, or high amounts
of hCD3e chains, whereas virtually all spleen and lymph node
T cells (i.e., mCD3+, Ig -) selectively express high levels of
hCD3e (Fig. 3 B). It is worth noting that,both in the thymus
and peripheral lymphoid organs, the transgenic and endoge-
nous CD3e chains were coexpressed in similar amounts on
the surface ofevery T cell, each in roughly half ofthe amount
of mCD3e found in nontransgenic littermates (Figs. 2 and
3). Thus, the total(h + m) amount ofCD3e chains expressed
in T cells from the transgenic mice approximately equals that
found in normal mice.
Second, we studied the association of hCD3e with cx/(3
or y/b types ofTCR. The majority of T cells in the thymus
and periphery express TCRci/(3associated with hCD3e (Fig.
2), whereas the T cells that arise first in ontogeny, occurring
in low numbers at day 15 in fetal thymus (25), instead bear
TCR-y/b associated with hCD3e, as found after analysis of
fresh thymocytes and confirmed using T cell lines and hy-
bridomas derived from that cell population (Fig. 3 C). Thus,
both T cell lineages express physiological levels of TCR,
hCD3e, and mCD3e during ontogeny and in the periphery.
Third, we analyzed the distribution of CD4 and CD8,
molecules implicated as TCR/CD3 coreceptors in the processes
of positive and negative selection of T cells (35). The abso-
lute number ofcells foundin lymphoid organs, and the propor-
tions of cells in T cell subsets defined by the expression of
CD4 and CD8 surface markers, were all within the range
found in nontransgenic littermates (Fig. 3 A, B, and D).
Finally, we monitored the effect upon in vivo selection of
TCR repertoires ofthe chimeric TCR/CD3 expressed in the
13
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transgenic mice T cells (Table 2). Bill et al. (26) have shown
that DBA/2 and [B6 x DBA/2]Fi (BDFI) mice have sig-
nificantly reduced numbers of V011 cells, whereas C57BL/6
(B6) T cells, which do not express E«E,a products necessary
for deletion of V,611-bearing T cells, do not have deletions
of T cells expressing V131, (26). The founder mice for our
hCD3e transgenic strains were BDF2, the initial backcross
was with B6 mice, and the positive offspring was subsequently
subjected to brother/sister mating. Therefore, the homozy-
gous transgenic individual analyzed can either bear or lack
expression of I-E gene products depending on the segrega-
tion of the MHC haplotype. We found that low frequencies
of Vptt-bearing T cells indeed correlate with the expression
of I-E in the CDR transgenic mice analyzed (Table 2). The
frequencies of T cells bearing either V06 or V08 domains are
not significantly modified in the same mice, indicating the
specificity of the deletion occurring in the transgenic mice
(Table 2) . We conclude that association of hCD3e with the
mouse TCR heterodimer and CD3 complex does not per-
turb negative selection during T cell development. In sum-
mary, afterthe analysis of >100 individuals from five different
transgenic lines from day 14 of fetal age to 1 yr old, it is
clear that the surface expression of hCD3e and the subse-
quent generation of h/m chimeric antigen receptors does not
disrupt normal T cell development in our homozygotic trans-
genic mice.
hCD3e-containing TCR/CD3 Complexes Are Functional in
Assays In Vitra We also asked whether the presence of hy-
brid hCD3e-mFCR/CD3 receptors in transgenic T cells affects
the function ofTCR/CD3 complex as measured by prolifer-
ation and cytotoxicity assays: spleen cells of the transgenic
mice showed a strong proliferative response to hCD3e-specific
mAb (Table 3). The response was similar to that obtained
using either mTCR-/3- or mCD3e-specific mAb in spleen cells
from both transgenic and nontransgenic mice. We examined
whether anti-CD3-stimulated cells expanded in IL-2 mediate
TCR/CD3-dependent cytolytic activity (Table 4). Target cells
coated with anti-hCD3e, as well as mCD3e- or OTCRspecific
Spleen cells were enriched for T cells using nylon wool columns (21), and 5 x 105 cells in each group were incubated with the indicated biotin-
conjugated Vg-specific mAb followed by streptavidin-peand FITC-labeled anti-mCD3. The number of cells stained by Vs-specific mAb is represent-
ed as a mean percentage ± SE of total CD3* cells of results obtained for individual mice, with 6-10 mice in each strain analyzed. Similar results
were obtained with TG41 strain. The level of expression of I-Ed molecules was measured in unfractionated spleen cellsusing FITC-conjugated 14.4.4
mAb and flow cytometry using an irrelevant CD2-specific mAb as negative control.
Table 2. Expression of V8TCR Domains in T cells
Cells stained with mAb specific for:
Strain Vsb Vds Vp11 Surface I-E expression
C57BL/6 8.9 ± 0.2 19.8 ± 0.6 4.8 ± 0.7 Negative
DBA/2 11.7 ± 0.3 24.1 ± 1.2 1.5 ± 0.2 Positive
[B6 x DBA/2]F1 10.9 ± 0.5 21.1 ± 0.7 1.3 ± 0.1 Positive
TG16 (I-E') 10.7 ± 0.6 22.8 ± 0.3 1.4 ± 0.3 Positive
TG16 (I-E-) 9.8 ± 0.3 19.2 ± 0.4 4.7 ± 0.6 NegativeTable 3 .
￿
Proliferation of Cells Stimulated with
Discussion
105 cells mice spleen or human peripheral blood cells were stimulated
with the indicated antibodies (0 .5 Ftg/ml) and cultured for 4 d in 200
P.1 complete medium (21, 30) . f3H]Methyl-thymidine was added to the
wells 8 h before the harvesting . Results show the mean thymidine incor-
poration of triplicate wells in one experiment representative of five per-
formed .
mAb, but not irrelevant antibodies, were efficiently killed by
transgenic T cells. Both the proliferative and cytotoxic re-
sponses promoted by anti-hCD3e mAb were specific since
they were not detected usingnontransgenic T cells . We con-
clude therefore that the hybrid hCD3e-mTCR/CD3 receptors
are functionally competent .
Immunoprecipitation andFRET analyses in T cells from
transgenic mice that carrythe hCD3e gene have shown that
the hCD3e chain is able to replacemCD3e subunits in the
assembled TCR/CD3 complex, and that transgenic TCRs
cancontainboth h- andmCD3e . Antigenmodulation studies
demonstrated that there are two CD3e chains per antigen
receptor and defined three receptor species, he/hE, he/ME,
and ME/ME, in a ratio of 1:2:1, respectively, suggesting a
stochastic useofhuman or mouse CD3E duringTCR/CD3
assembly. The chimeric antigen receptors support normal T
cell development and selection of repertoires in vivo and are
14 Two CD3E Subunits in the T Cell Receptor
Table 4 .
￿
hCWE-containing Antigen Receptor Complexes Are
5 x 104 mouse spleen or human peripheral blood T cells that had been
polyclonally stimulated with anti-CD3 antibodies and cultured for 10 d
in the presence of 25 U/ml rll-2 (21) were used as effector cells . They
were incubated for 4 h at different E/T ratios with SICr-labeled U937
cells precoated with the indicated antibodies (30) . Results show the
mean ± SE 5'Cr-specific release at 10:1 E/T ratio in one experiment
representative of four performed.
able to transduce activation signals in vitro . These findings
imply that hCD3e canboth structurally andfunctionally sub-
stitute for mCD3e in the transgenic mouse strains studied
and show that theTCR/CD3 complex contains two CD3E
subunits.
Previously, the subunit stoichiometry of the TCR/CD3
complex was considered to be either aaybef2 or aoybc-~,q
(18-20). However, conclusive data supporting such arepresen-
tation are lacking. The demonstration that there aretwo CD3e
chains in a functional antigen receptor, together with the
data of otherworkers, allows us to present a minimal model
for the TCR/CD3 complex (Fig. 4) . Several biochemical
studies of partial receptor complexes have demonstrated four
preferential subunit pairs : a/(3, f2, y/E, and 8/E (but not
CD3,y/S ; 36-38), and the model is built up from these pairs .
The TCR-a/(3 and f2 dimers can associate with each other
in the absence ofCD3 (37), suggesting that the most impor-
tant structural interaction of f2 is with the TCR hetero-
dimer (Fig. 4) . Chemical crosslinking experiments indicate
Figure 4.
￿
Minimal model of the TCR/CD3 complex .
(A) Cross-section through the T cellmembrane showing
the stoichiometry and associations ofTCR/CD3 subunits .
"Like" subunits(TCRa and -a; CD3-y and -6) are shaded
identically to emphasize structural symmetry. (B) Plan
view of the receptor from outside the T cell . Disulfide
bonds are shown as solid (TCRa/a) or dotted (~-O lines .
TCR/CD3-specific Antibodies Functional in Cytoxicity Assays
Proliferation of cells stimulated with : Percentage of specific lysis of U937
Cell source hCD2 HCD3E mCD3e mTCR-/3
Effector T cell origin hCD2
cells
hCD3e
coated with :
mCD3e mTCR-a
cpm
TG16 1,583 37,051 43,808 38,944 TG16 6±1 86±5 82±6 79±4
Nontransgenic Nontransgenic
littermate 1,897 1,766 46,122 39,577 littermate 7 ± 4 5 ± 2 91 ± 4 81 ± 6
Human Human
peripheral blood 1,193 53,873 1,087 1,154 peripheral blood 8 ± 1 91 ± 5 7 ± 2 7 ± 1the proximity of CD3y to TCR-0 (38, 39) and of CD3e
to both TCR-a and-0(38). This is consistent with a CD3y/e
heterodimer lying adjacent to the TCR,3 chain ofthe receptor,
and a CD3S/e pair flanking TCRa (Fig. 4).
The model predicts that CD36 contacts TCR-a and not
-(3, and further suggests that specificity of contact between
CD3 chains and TCR-a or -(3 must reside in the CD3y and
-S subunits, since CD3e associates with both chains of the
TCR heterodimer. However, such specificity must also allow
association of CD3 with TCR-y/S chains. We have shown
expression of the human CD3e chain on y/S T cells from
E-transgenic mice, and, although we have not investigated
the structure of the TCR-y/S/CD3 complex in detail, we
feel it is likely that the overall organization will be similar
to that of TCR-y/O/CD3. Considering the demonstration
of a functional TCR-S/0/CD3 complex (40), the most par-
simonious interpretation would be that TCR-S and -y sub-
stitute for TCR a and i(3 chains, respectively, in the TCR-
y/S/CD3 complex.
The minimal model for the TCR has a stoichiometry of
UOy8e2~2. While more complex stoichiometries are conceiv-
able, particularly since at present the minimum representa-
tion of chains other than CD3e and -~ is not clear, certain
of these structures are improbable. For example, a TCR/CD3
complex containing two copies of each CD3 subunit
(y2S2e2) is unlikely for the following reasons. Since CD3y/S
dimers are not found (36-38), a CD3ya82Q complex would
have to be grouped as trimers, either ('YSE)2 or ,y2E plus Sae.
CD3y/S/e subcomplexes have not been documented: al-
though anti-CD3y sera coprecipitate CD3e, they do not de-
tect CD38. Similarly, anti-CD3S sera do not coprecipitate
CD3y (38) . Previous immunoprecipitation data suggesting
a CD3y/S/E trimer (37, 41) can be seen as the simultaneous
precipitation ofy/E and 8/e species by the CD3e-specific an-
tibodies used. Therefore, an antigen receptor with a represen-
tation of CD3y2S2E2 would involve the formation ofy2e and
See trimers. This would require CD3E to possess duplicated
association sites for both CD3y and -S chains, or to bind
one subunit of a -y/,y (or S/S) dimer. Although possible, these
arrangements seem artificially complex compared with the
simple y/E and S/E dimers proposed in Fig. 4, where CD3y
and -S associate in a mutually exclusive manner with CD3E,
possibly competing for the same binding site on the CD3e
protein. This is consistent with the high degree of related-
ness of CD3y and -S: one or both of the two conserved se-
quence motifs found in all CD3y and -S proteins from three
species (42) may be involved in association with CD3e. How-
ever, additional experiments will be required to provide di-
rect evidence for the stoichiometry of other receptor compo-
nents and, in particular, to examine the intriguing possibility
that the antigen binding subunits could form a tetramer
(a202), like Igs, rather than a dimer.
There are a number of consequences of a TCR with two
CD3e subunits. (a) The majority of CD3-specific mAbs recog-
nize epitopes conferred by CD3e (21, 43) and therefore have
the potential to form strings oflinked TCR/CD3 complexes
on the cell surface. This crosslinking function may be the
critical mitogenic property of CD3-specific mAbs, since an-
tibodies monovalent for CD3 are nonstimulatory in the ab-
sence ofsecondary crosslinking (44). (b) CD3e-specific mAbs
may also crosslink the two CD3e chains within a single TCR,
assuming no steric hindrance from other subunits. It is con-
ceivable that inter-receptor and intra-receptor crosslinking
might lead to qualitatively or quantitatively different intra-
cellular signals. (c) If a TCR/CD3 complex contains a single
a/(3 heterodimer, TCR-a//.3-specific mAbs would have only
a limited capacity for receptor crosslinking. This contrasts
with CD3e-specific mAbs, and might account for differences
in the abilities of the two types ofmAbs to stimulate T cells
during T cell selection in thymus organ culture (45) .
Interspecies polymorphism and complementation of TCR/
CD3 subunits allowed the definition of CD3e stoichiometry
in transgenic mouse T cells. The transgenic approach to the
analysis ofstructure/function relationships ofthe TCR offers
several advantages over in vitro systems. It can facilitate the
examination of the structure of the receptor: (a) at early de-
velopmental stages, where there is limited knowledge of
TCR/CD3 subunit expression, assembly, and function; (b)
during negative and positive selection processes; and (c) in
the several lineages and subsets derived from T cell precursors,
since the different cell populations (or lines) characterized in
each strain have the same defined genetic background and
do not need to be transformed. Transgenic mice may prove
to be of general value as a technique for the analysis of com-
plex receptors.
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